S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
NYSE:RCUS

Arcus Biosciences SEC Filings & 10K Form

$34.39
+1.88 (+5.78 %)
(As of 10/15/2021 12:00 AM ET)
Add
Compare
Today's Range
$32.57
$35.15
50-Day Range
$26.93
$37.68
52-Week Range
$18.51
$42.36
Volume470,871 shs
Average Volume572,047 shs
Market Capitalization$2.46 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.15

Arcus Biosciences (NYSE:RCUS) SEC Filings

DateFilerForm TypeView
08/05/2021
3:19 PM
Arcus Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/19/2021
4:16 PM
Arcus Biosciences (Subject)
EcoR1 Capital, LLC (Filed by)
Form SC 13G
06/07/2021
3:47 PM
Arcus Biosciences (Issuer)
Jarrett Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2021
3:44 PM
Arcus Biosciences (Issuer)
Ribas Antoni (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2021
3:42 PM
Arcus Biosciences (Issuer)
PERLMAN ANDREW J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2021
3:40 PM
Arcus Biosciences (Issuer)
Machado Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2021
3:38 PM
Arcus Biosciences (Issuer)
Lacey David L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2021
3:36 PM
Arcus Biosciences (Issuer)
KANEKO YASUNORI (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2021
3:34 PM
Arcus Biosciences (Issuer)
FALBERG KATHRYN E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2021
3:26 PM
Arcus Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/05/2021
3:19 PM
Arcus Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/26/2021
3:16 PM
Arcus Biosciences (Issuer)
KANEKO YASUNORI (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/26/2021
3:14 PM
Arcus Biosciences (Issuer)
Grossman William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/20/2021
3:14 PM
Arcus Biosciences (Filer)
Form DEFA14A
04/02/2021
10:38 AM
Arcus Biosciences (Issuer)
FALBERG KATHRYN E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2021
3:37 PM
Arcus Biosciences (Issuer)
Grossman William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2021
3:36 PM
Arcus Biosciences (Issuer)
Jarrett Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2021
3:13 PM
Arcus Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/16/2021
3:43 PM
Arcus Biosciences (Subject)
Boxer Capital, LLC (Filed by)
Form SC 13G/A
02/04/2021
4:02 PM
Arcus Biosciences (Issuer)
ROSEN TERRY J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2021
1:56 PM
Arcus Biosciences (Subject)
BlackRock Inc. (Filed by)
Form SC 13G
02/01/2021
7:08 AM
Arcus Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/20/2021
3:16 PM
Arcus Biosciences (Issuer)
Tang Carolyn C. (Reporting)
Tang Carolyn C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/20/2021
3:14 PM
Arcus Biosciences (Issuer)
Arcus Biosciences (Issuer)
ROSEN TERRY J (Reporting)
ROSEN TERRY J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/20/2021
3:13 PM
Arcus Biosciences (Issuer)
Jarrett Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/20/2021
3:12 PM
Arcus Biosciences (Issuer)
Jaen Juan C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/20/2021
3:11 PM
Arcus Biosciences (Issuer)
Grossman William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/20/2021
3:10 PM
Arcus Biosciences (Issuer)
Goeltz II Robert C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2021
3:15 PM
Arcus Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2020
6:58 PM
Arcus Biosciences (Issuer)
PERLMAN ANDREW J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2020
3:51 PM
Arcus Biosciences (Issuer)
Grossman William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2020
3:21 PM
Arcus Biosciences (Issuer)
Tang Carolyn C. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/18/2020
3:17 PM
Arcus Biosciences (Issuer)
PERLMAN ANDREW J (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/10/2020
4:16 PM
Arcus Biosciences (Subject)
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Form SC 13G/A
11/09/2020
3:01 PM
Arcus Biosciences (Subject)
PFM Health Sciences, LP (Filed by)
Form SC 13G
11/05/2020
3:25 PM
Arcus Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2020
3:52 PM
Arcus Biosciences (Subject)
COLUMN GROUP II, LP (Filed by)
Form SC 13G/A
10/15/2020
3:46 PM
Arcus Biosciences (Issuer)
Jaen Juan C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2020
3:42 PM
Arcus Biosciences (Subject)
Jaen Juan C. (Filed by)
Form SC 13D
10/05/2020
4:02 PM
Arcus Biosciences (Issuer)
Grossman William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2020
4:01 PM
Arcus Biosciences (Issuer)
Jarrett Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2020
3:50 PM
Arcus Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2020
3:53 PM
Arcus Biosciences (Issuer)
Goeltz II Robert C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2020
4:13 PM
Arcus Biosciences (Issuer)
ROSEN TERRY J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2020
3:16 PM
Arcus Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/04/2020
5:53 PM
Arcus Biosciences (Issuer)
Goeltz II Robert C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/04/2020
5:15 PM
Arcus Biosciences (Issuer)
Goeltz II Robert C. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/04/2020
5:13 PM
Arcus Biosciences (Issuer)
Grossman William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2020
1:01 PM
Arcus Biosciences (Subject)
GILEAD SCIENCES INC (Filed by)
Form SC 13D
07/17/2020
1:00 PM
Arcus Biosciences (Issuer)
GILEAD SCIENCES INC (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/13/2020
4:59 PM
Arcus Biosciences (Issuer)
Parsey Merdad (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/07/2020
3:14 PM
Arcus Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/08/2020
3:35 PM
Arcus Biosciences (Issuer)
ROSEN TERRY J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
3:22 PM
Arcus Biosciences (Issuer)
Barker Jason (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2020
4:27 PM
Arcus Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/29/2020
4:16 PM
Arcus Biosciences (Filer)
Form 424B5
05/27/2020
8:29 PM
Arcus Biosciences (Filer)
Form 424B5
05/27/2020
3:38 PM
Arcus Biosciences (Filer)
Form S-3ASR
05/27/2020
6:44 AM
Arcus Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/26/2020
3:18 PM
Arcus Biosciences (Issuer)
Lacey David L. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/26/2020
3:16 PM
Arcus Biosciences (Filer)
Form DEFA14A
05/26/2020
3:13 PM
Arcus Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/05/2020
3:15 PM
Arcus Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/21/2020
3:18 PM
Arcus Biosciences (Filer)
Form DEFA14A
04/21/2020
3:11 PM
Arcus Biosciences (Filer)
Form DEF 14A
04/07/2020
7:31 AM
Arcus Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2020
3:44 PM
Arcus Biosciences (Subject)
Jaen Juan C. (Filed by)
Form SC 13D
03/05/2020
3:41 PM
Arcus Biosciences (Subject)
ROSEN TERRY J (Filed by)
Form SC 13D
03/05/2020
3:39 PM
Arcus Biosciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/05/2020
3:14 PM
Arcus Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2020
1:59 PM
Arcus Biosciences (Subject)
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Form SC 13G/A
02/13/2020
2:05 PM
Arcus Biosciences (Subject)
Boxer Capital, LLC (Filed by)
Form SC 13G
01/27/2020
2:36 PM
Arcus Biosciences (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
01/22/2020
9:57 AM
Arcus Biosciences (Issuer)
ROSEN TERRY J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2020
9:52 AM
Arcus Biosciences (Issuer)
Ribas Antoni (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2020
9:49 AM
Arcus Biosciences (Issuer)
Jaen Juan C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2020
9:44 AM
Arcus Biosciences (Issuer)
Grossman William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2020
9:38 AM
Arcus Biosciences (Issuer)
Barker Jason (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2019
11:18 AM
Arcus Biosciences (Issuer)
Machado Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2019
11:11 AM
Arcus Biosciences (Issuer)
Machado Patrick (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/12/2019
8:03 AM
Arcus Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/25/2019
3:05 PM
Arcus Biosciences (Filer)
Form 8-K/A
11/05/2019
3:30 PM
Arcus Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2019
3:23 PM
Arcus Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2019
3:15 PM
Arcus Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2019
5:15 PM
Arcus Biosciences (Issuer)
Grossman William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2019
3:00 PM
Arcus Biosciences (Issuer)
Barker Jason (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/16/2019
3:12 PM
Arcus Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/03/2019
3:10 PM
Arcus Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2019
3:18 PM
Arcus Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/28/2019
6:07 PM
Arcus Biosciences (Issuer)
Jaen Juan C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
1:24 PM
Arcus Biosciences (Issuer)
FALBERG KATHRYN E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
7:01 PM
Arcus Biosciences (Issuer)
FALBERG KATHRYN E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2019
7:19 PM
Arcus Biosciences (Issuer)
FALBERG KATHRYN E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2019
2:14 PM
Arcus Biosciences (Issuer)
KANEKO YASUNORI (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2019
2:10 PM
Arcus Biosciences (Issuer)
Jarrett Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2019
2:07 PM
Arcus Biosciences (Issuer)
Hege Kristen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2019
2:04 PM
Arcus Biosciences (Issuer)
FALBERG KATHRYN E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2019
1:59 PM
Arcus Biosciences (Issuer)
BEIER DAVID W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
1:03 PM
Arcus Biosciences (Issuer)
ROSEN TERRY J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 10/16/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.